Skip to content
value.today

Tactile Systems Technology, Inc.: financial analysis

Ratios worked out from 10 fiscal years of Tactile Systems Technology, Inc.'s statements, compared with 102 companies in Medical Devices.

Operating margin, 2025
8.9%
Medical Devices: -8.2%
Return on equity, 2025
8.8%
Medical Devices: -16.8%
Revenue growth, 3 years a year, 2025
10.1%
Medical Devices: 10.8%
Debt to equity, 2025
0.00×
Medical Devices: 0.64×

Tactile Systems Technology, Inc. scorecard#

Passes 21 of the 26 checks that could be worked out: strongest in financial health (5 of 5), weakest in valuation (4 of 6). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation4 of 6
    • ✓P/E below its peers' median22.9×P/E 22.9× against Medical Devices's median of 24.1×.
    • ✗Price to book below its peers' median2.5×Price to book 2.5× against Medical Devices's median of 2.5×.
    • ✓Price to sales below its peers' median1.5×Price to sales 1.5× against Medical Devices's median of 2.4×.
    • ✓Free cash flow yield above 5%7.4%Free cash flow is 7.4% of the market value.
    • ✗Earnings yield above the 10-year Treasury yield4.4%Earnings yield 4.4% against the 10-year Treasury's 5.15% on 2026-11-13.
    • ✓The price assumes slower growth than the last three years'1.3%The price assumes 1.3% a year for ten years; revenue grew 10.1% a year over the last three.
  • Growth5 of 6
    • ✓Revenue grew in the newest year12.5%Revenue up 12.5% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years10.1%10.1% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median10.1%10.1% a year against Medical Devices's median of 10.8% (73 companies).
    • ✓Earnings per share grew in the newest year0.82 vs 0.70Diluted EPS 0.82 in fiscal 2025 against 0.70 the year before (report's currency).
    • ✓Net income higher than five years earlier$19 M$19 M in fiscal 2025 against -$1 M in 2020.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
  • Profitability4 of 6
    • ✓Profitable in the newest year$19 MNet income $19 M in fiscal 2025.
    • ✗Profitable in each of the last five years3 of 5Profitable in 3 of the five years to fiscal 2025.
    • ✓Operating margin above its peers' median8.9%8.9% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%8.8%8.8% in fiscal 2025.
    • ✓Return on invested capital above 10%13.2%13.2% in fiscal 2025.
    • ✓Operating margin wider than three years earlier8.9%8.9% in fiscal 2025 against -5.2% in 2022.
  • Financial health5 of 5
    • ✓Short-term assets cover short-term liabilities4.0×Current ratio 4.03 at the end of fiscal 2025.
    • ✓Debt below equity0.0×Debt to equity 0.00 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $83 M at the end of fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone8.32Z-score 8.32 (safe zone) for fiscal 2025.
  • Shareholder returns3 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year-3.5%Diluted shares down 3.5% in fiscal 2025.
    • ✓Dividends and buybacks above 3% of the market value4.9%Dividends and buybacks were 4.9% of the market value.
    • ✓Free cash flow covers dividends and buybacks$40 MFree cash flow $40 M against $27 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

What the 2025 statements show#

Each line is an observation with its numbers, not a judgement of the company.

Strengths

  • Revenue has grown 5 years in a row.
  • Free cash flow has been positive 6 years in a row.
  • The share count fell 3.5% in the year (buybacks).
  • More cash than debt: net cash of $83 million.

Piotroski F-score

Nine yes/no tests of whether the company's finances improved in the year. One point each.

7of 8(1 of the nine tests cannot be worked out from the statements on file, so there is no full score)
  • Made a profityes
  • Operations brought in cashyes
  • Return on assets roseyes
  • Cash from operations exceeds profityes
  • Long-term debt fell against assetsnot on file
  • Current ratio roseno
  • No new shares issuedyes
  • Gross margin roseyes
  • Asset turnover roseyes

Altman Z-score

A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.

8.32Safe zone(above 2.99, where the formula's author found few failures)
The five parts of the Altman Z-score
PartRatioWeightPoints
Working capital to assets0.45× 1.20.54
Retained earnings to assets0.20× 1.40.28
Operating income to assets0.11× 3.30.35
Market value to liabilities9.89× 0.65.94
Revenue to assets1.20× 11.20

Where the return on equity comes from

The DuPont split: margin, times how hard the assets work, times how much of them is financed by others.

Net margin5.8%Asset turnover1.15×Assets to equity1.32×Return on equity8.8%

Profitability#

Tactile Systems Technology, Inc.: profitability by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Gross margin75.9%74.0%71.1%71.3%71.2%62.9%78%
Operating margin8.9%7.6%6.6%-5.2%-0.9%-8.2%72%
Net margin5.8%5.8%10.4%-7.2%-5.7%-10.4%71%
Return on equity8.8%8.3%18.1%-14.3%-9.3%-16.8%73%
Return on assets6.7%5.9%10.6%-7.2%-5.7%-12.7%80%
Return on invested capital13.2%————10.6%73%

Growth#

Tactile Systems Technology, Inc.: growth by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Revenue growth12.5%6.8%11.2%18.6%11.2%10.4%55%
Revenue growth, 3 years a year10.1%12.1%13.6%9.2%13.1%10.8%44%
Revenue growth, 5 years a year12.0%9.1%13.8%17.7%19.7%15.3%40%
Net income growth12.6%-40.5%———5.7%56%
Earnings per share growth17.1%-43.1%———3.3%71%

Financial strength#

Tactile Systems Technology, Inc.: financial strength by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Debt to equity0.00×—0.09×——0.64×98%
Net debt$-83 M—$-44 M——$10 M93%
Net debt to EBITDA-2.32×—-1.80×——1.68×100%
Current ratio4.03×4.36×3.54×1.86×3.30×3.30×62%
Equity share of assets79.9%72.7%68.8%47.6%52.5%54.6%83%

Cash#

Tactile Systems Technology, Inc.: cash by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Free cash flow$40 M$38 M$34 M$3 M$1 M$-3 M75%
Free cash flow margin12.3%13.1%12.2%1.4%0.3%-1.9%76%
Cash conversion224.3%239.7%125.7%——152.3%76%
Capital spending share of revenue0.7%0.8%0.9%0.7%1.0%2.5%—

Shareholder returns#

Tactile Systems Technology, Inc.: shareholder returns by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Buyback yield4.9%————1.2%87%
Shareholder yield4.9%————1.5%89%
Change in share count-3.5%4.2%15.5%1.8%1.9%4.1%96%

Efficiency#

Tactile Systems Technology, Inc.: efficiency by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Asset turnover1.15×1.01×1.02×0.99×0.99×0.64×87%

How each figure is worked out#

Gross margin
Gross profit as a share of revenue.
Operating margin
Operating income as a share of revenue.
Net margin
Net income as a share of revenue.
Return on equity
Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
Return on assets
Net income as a share of total assets (average of the year).
Return on invested capital
Operating income after tax, as a share of debt plus equity less cash (average of the year). The tax rate is the year's own: income tax over pre-tax income.
Revenue growth
Revenue against the year before.
Revenue growth, 3 years a year
The yearly rate that takes revenue of three years earlier to this year's.
Revenue growth, 5 years a year
The yearly rate that takes revenue of five years earlier to this year's.
Net income growth
Net income against the year before. Only when both years were profitable.
Earnings per share growth
Diluted earnings per share against the year before. Only when both were positive.
Debt to equity
Total debt divided by shareholders' equity. Not given when equity is negative.
Net debt
Total debt less cash. Negative means more cash than debt.
Net debt to EBITDA
Debt less cash, divided by operating income plus depreciation and amortization: roughly the years of operating earnings needed to repay it.
Current ratio
Assets due within a year divided by liabilities due within a year.
Equity share of assets
Shareholders' equity as a share of total assets.
Free cash flow
Cash from operations less capital spending.
Free cash flow margin
Free cash flow as a share of revenue.
Cash conversion
Cash from operations as a share of net income. Only when the year was profitable.
Capital spending share of revenue
Capital spending as a share of revenue.
Buyback yield
Shares bought back in the fiscal year as a share of today's market value.
Shareholder yield
Dividends plus buybacks as a share of today's market value.
Change in share count
Diluted shares against the year before. Negative: fewer shares.
Asset turnover
Revenue divided by total assets (average of the year).

Source: Tactile Systems Technology, Inc.'s statements: annual reports filed with the SEC. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). "Ahead of" is the share of the 102 companies in Medical Devices that Tactile Systems Technology, Inc. is better than on that figure, using each company's newest fiscal year; yields use today's market value. Medians for every industry · Back to Tactile Systems Technology, Inc.